BATONI, GIOVANNA
 Distribuzione geografica
Continente #
NA - Nord America 10.453
AS - Asia 5.164
EU - Europa 4.502
SA - Sud America 743
AF - Africa 240
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 21.113
Nazione #
US - Stati Uniti d'America 10.170
SG - Singapore 1.707
CN - Cina 1.672
IT - Italia 1.412
SE - Svezia 820
HK - Hong Kong 717
BR - Brasile 637
DE - Germania 554
BG - Bulgaria 314
GB - Regno Unito 271
VN - Vietnam 245
TR - Turchia 240
CA - Canada 201
FI - Finlandia 199
KR - Corea 184
RU - Federazione Russa 180
UA - Ucraina 147
IN - India 129
AT - Austria 114
IE - Irlanda 113
FR - Francia 106
SN - Senegal 75
NL - Olanda 62
CH - Svizzera 61
CI - Costa d'Avorio 59
JP - Giappone 47
MX - Messico 44
BE - Belgio 42
AR - Argentina 40
PL - Polonia 30
BD - Bangladesh 29
ID - Indonesia 25
IQ - Iraq 21
PK - Pakistan 20
ZA - Sudafrica 20
ES - Italia 18
NG - Nigeria 17
EG - Egitto 16
EC - Ecuador 15
VE - Venezuela 14
CZ - Repubblica Ceca 13
UZ - Uzbekistan 13
MA - Marocco 12
SA - Arabia Saudita 11
CO - Colombia 10
NP - Nepal 10
PE - Perù 10
TW - Taiwan 10
AE - Emirati Arabi Uniti 9
AL - Albania 9
KE - Kenya 9
PH - Filippine 9
DZ - Algeria 8
JO - Giordania 7
KZ - Kazakistan 7
AU - Australia 6
DO - Repubblica Dominicana 6
JM - Giamaica 6
MY - Malesia 6
TH - Thailandia 6
AZ - Azerbaigian 5
BJ - Benin 5
CL - Cile 5
ET - Etiopia 5
IL - Israele 5
OM - Oman 5
PA - Panama 5
TT - Trinidad e Tobago 5
CR - Costa Rica 4
DK - Danimarca 4
LT - Lituania 4
PT - Portogallo 4
PY - Paraguay 4
QA - Qatar 4
UY - Uruguay 4
AM - Armenia 3
BB - Barbados 3
BO - Bolivia 3
CG - Congo 3
GA - Gabon 3
GR - Grecia 3
IR - Iran 3
LV - Lettonia 3
MD - Moldavia 3
NO - Norvegia 3
BS - Bahamas 2
BY - Bielorussia 2
CY - Cipro 2
EU - Europa 2
GT - Guatemala 2
LB - Libano 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
RO - Romania 2
SD - Sudan 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
ZW - Zimbabwe 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
Totale 21.090
Città #
Woodbridge 1.311
Ashburn 1.046
Singapore 885
Ann Arbor 883
Hong Kong 708
Santa Clara 707
Fairfield 686
Houston 663
Chandler 635
Dallas 556
Shanghai 344
Beijing 334
Sofia 310
Seattle 281
Serra 264
Wilmington 262
Hefei 261
Cambridge 246
New York 232
Milan 197
Seoul 179
Izmir 170
Jacksonville 168
Los Angeles 161
Ottawa 161
Boardman 157
Princeton 145
Lawrence 124
Medford 106
Pisa 105
Dublin 96
Florence 96
Nanjing 95
Bremen 94
Vienna 90
Munich 87
Des Moines 82
Dakar 75
London 62
Dong Ket 61
Abidjan 59
Frankfurt am Main 59
Chicago 57
Bern 56
Dearborn 55
Buffalo 54
Istanbul 54
Nanchang 49
Redondo Beach 47
Helsinki 42
The Dalles 42
San Diego 41
São Paulo 40
Brussels 38
Tokyo 38
Ho Chi Minh City 36
Lancaster 35
Columbus 34
Falls Church 34
Council Bluffs 33
Livorno 33
Pune 32
Kunming 31
Somma Lombardo 31
Fuzhou 29
Turku 29
Jüchen 27
Quanzhou 27
Rome 27
Boulder 25
Ogden 24
Redwood City 24
Lucca 22
San Jose 22
Changsha 21
Guangzhou 21
Phoenix 20
Warsaw 20
Belo Horizonte 18
Manchester 18
Marseille 18
Nuremberg 18
Tianjin 18
Shenyang 17
Curitiba 16
Hanoi 16
Nürnberg 16
Orem 16
Rio de Janeiro 16
Denver 15
Jakarta 15
Lagos 15
Brasília 14
Hebei 14
Nieuwegein 14
Paris 14
San Francisco 14
Alessandria 13
Jiaxing 13
Lappeenranta 13
Totale 14.834
Nome #
Biofilm growth on orthopedic implantable materials: static or dynamic condition what is the most appropriate methodological tools to study device-related infections? 335
The ESX-5 Associated eccB-eccC Locus Is Essential for Mycobacterium tuberculosis Viability 262
Chitosan nanoparticles for the linear release of model cationic peptide 261
Betaine- and L-Carnitine-Based Ionic Liquids as Solubilising and Stabilising Agents for the Formulation of Antimicrobial Eye Drops Containing Diacerein 246
Insights into the Antimicrobial Properties of Hepcidins: Advantages and Drawbacks as Potential Therapeutic Agents 237
T and B immunogenicity of SA5K a secretion antigen of Mycobacterium tuberculosis, in healthy subjects and in tuberculosis patients 224
COMPLETE RELEASE OF ADENOSINE-DEAMINASE FROM MOUSE LYMPHOCYTES STABILIZED BY LOW-PH ACETATE 213
Detection of Biofilms in Biopsies from Chronic Rhinosinusitis Patients: In Vitro Biofilm Forming Ability and Antimicrobial Susceptibility Testing in Biofilm Mode of Growth of Isolated Bacteria 204
Human CD56bright and CD56dim Natural Killer Cell Subsets Respond Differentially to Direct Stimulation with Mycobacterium bovis Bacillus Calmette-Guérin 202
Structure-Activity Relationships on Purine and 2,3-Dihydropurine Derivatives as Antitubercular Agents: a Data Mining Approach 199
Anti-biofilm properties of the antimicrobial peptide temporin 1Tb and its ability, in combination with EDTA, to eradicate Staphylococcus epidermidis biofilms on silicone catheters 196
Identification, molecular cloning, and evaluation of potential use of isocitrate dehydrogenase II of Mycobacterium bovis BCG in serodiagnosis of tuberculosis 191
Evaluation of the inhibitory effects of human serum components on bactericidal activity of human beta defensin 3 191
Influence of culture medium on the resistance and response of Mycobacterium bovis BCG to reactive nitrogen intermediates 191
QUESTIONING THE ROLE OF ADENOSINE-DEAMINASE IN THE DEVELOPMENT OF LYMPHOCYTE-B IN CHICKEN BURSA 188
A comparison of various EIA plates for the analysis of poly-saccharide antigens and serological identification of Oral Streptococchi. New perspective on streptococci and streptococcal infections 188
Modelli dinamici nello studio del biofilm sui materiali protesici 186
Antibacterial, Antibiofilm, and Antiadhesive Properties of Different Quaternized Chitosan Derivatives 186
Involvement of the Mycobacterium tuberculosis secreted antigen SA-5K in intracellular survival of recombinant Mycobacterium smegmatis 184
Disruption of the ESX-5 system of Mycobacterium tuberculosis causes loss of PPE protein secretion, reduction of cell wall integrity and strong attenuation. 182
Antimicrobial activity of human hepcidin 20 and 25 against clinically relevant bacterial strains: effect of copper and acidic pH 180
In vitro bactericidal activity of the N-terminal fragment of the frog peptide esculentin-1b (Esc 1-18) in combination with conventional antibiotics against Stenotrophomonas maltophilia 178
PURINE METABOLISM AND B-LYMPHOCYTE DEVELOPMENT IN THE CHICKEN BURSA OF FABRICIUS 177
Prediction Model on Optionally Substituted 5,6-Membered Fused Ring Systems Containing C and/or N Atoms as Antifungal Agents Against Candida albicans Developed by Data Mining 173
Purification, biochemical characterization and immunogenicity of SA5K, a secretion antigen of Mycobacterium tuberculosis 173
Monoclonal antibodies specific for a polysaccharide antigenic determinant of Streptococcus mutans (serotypes c,e,f) 171
Identification and molecular cloning of a novel secretion antigen from Mycobacterium tuberculosis and Mycobacterium bovis BCG. 171
Disruption of the gene encoding for secretion antigen SA5K affects growth of Mycobacterium bovis bacillus Calmette-Guérin in human macrophages and in mice 171
Fungicidal activity of the human peptide hepcidin 20 alone or in combination with other antifungals against Candida glabrata isolates 171
Ulvan as novel reducing and stabilizing agent from renewable algal biomass: Application to green synthesis of silver nanoparticles 171
Identification of distinct lymphocyte subsets responding to subcellular fractions of Mycobacterium bovis bacille calmette-Guerin (BCG) 170
Integrated three-dimensional fiber/hydrogel biphasic scaffolds for periodontal bone tissue engineering 170
EFFECT OF REMOVABLE ORTHODONTIC APPLIANCES ON ORAL COLONISATION BY MUTANS STREPTOCOCCI IN CHILDREN 168
Generation of persister cells of Pseudomonas aeruginosa and Staphylococcus aureus by chemical treatment and evaluation of their susceptibility to membrane-targeting agents 167
Prediction model on optionalli substituted 5,6-membered fused ring systems containing C and/or N atoms as antifungal agents against Candida albicans developed by data mining 166
Lymphocytic purine metabolic disorders in tubercolin anergic mice 165
Miocardiopatie dilatative e miocarditi: eziopatogenesi virale 164
Antimicrobial peptides: promising molecules for the treatment of biofilm-associated infections. 164
Analogs of the Frog-skin Antimicrobial Peptide Temporin 1Tb Exhibit a Wider Spectrum of Activity and a Stronger Antibiofilm Potential as Compared to the Parental Peptide 164
The semi-synthetic peptide Lin-SB056-1 in combination with EDTA exerts strong antimicrobial and antibiofilm activity against pseudomonas aeruginosa in conditions mimicking cystic fibrosis sputum 164
Innovative Biobased and Sustainable Polymer Packaging Solutions for Extending Bread Shelf Life: A Review 160
Distribution of azithromycin in plasma and tonsil tissue after repeated oral administration of 10 or 20 milligrams per kilogram in pediatric patients 160
Analysis of the Mycobacterium bovis hsp60 promoter activity in recombinant Mycobacterium avium 160
Comparative analysis of bactericidal activity of amphibian peptide analogues against multidrug-resistant nosocomial bacterial strains 159
Comparative analysis of subcellular distribution of protein antigens in Mycobacterium bovis Bacillus Calmette-Guerin 157
Antivirulence properties of a low-molecular-weight quaternized chitosan derivative against pseudomonas aeruginosa 156
Human gamma-delta+ T cell responses to mycobacterial soluble extracts 155
First characterization in Italy of clinical isolates of mutans streptococci by using specific monoclonal antibodies. 155
Direct binding of human NK cell natural cytotoxicity receptor NKp44 to the surfaces of mycobacteria and other bacteria 155
Microbiologia del cavo orale 154
Clonaggio molecolare di un nuovo antigene di secrezione di Mycobacterium tuberculosis e Mycobacterium bovis BCG 153
BaAMPs: The database of biofilm-active antimicrobial peptides 153
In vitro Interaction of Pseudomonas aeruginosa Biofilms With Human Peripheral Blood Mononuclear Cells 153
Identification of a novel Mycobacterium bovis BCG secretion protein 152
Expression of SA5K, a secretion antigen of Mycobacterium tuberculosis, inside human macrophages and in sputum from tuberculosis patients 152
Targeting pseudomonas aeruginosa in the sputum of primary ciliary dyskinesia patients with a combinatorial strategy having antibacterial and anti-virulence potential 152
Streptococcus mutans has a polysaccharide antigenic determinant in common with Streptococcus porcinus 151
Allestimento di un saggio di RT-PCR per la valutazione dell'espressione di proteine micobatteriche in campioni di espettorato 150
Perspectives on polymeric nanostructures for the therapeutic application of antimicrobial peptides 150
Reduced human beta defensin 3 in individuals with periodontal disease 149
Characterization of antigens recognized by new monoclonal antibodies raised against culture filtrate proteins of Mycobacterium bovis bacillus Calmette-Guerin 149
1ST CHARACTERIZATION IN ITALY OF CLINICAL ISOLATES OF MUTANS STREPTOCOCCI BY USING SPECIFIC MONOCLONAL-ANTIBODIES 148
Gingipains produced by Porphyromonas gingivalis ATCC49417 degrade human-beta-defensin 3 and affect peptide's antibacterial activity in vitro 148
Human beta-defensin-3: a promising antimicrobial peptide 147
The anti-microbial peptide (Lin-SB056-1)2-K reduces pro-inflammatory cytokine release through interaction with Pseudomonas aeruginosa lipopolysaccharide 147
Use of antimicrobial peptides against microbial biofilms: advantages and limits 146
Functional characterization of human natural killer cells responding to Mycobacterium bovis bacillus Calmette-Guérin 144
Antibacterial and Antibiofilm Effects of Lactobacilli Strains against Clinical Isolates of Pseudomonas aeruginosa under Conditions Relevant to Cystic Fibrosis 143
HIV-1 proviral DNA sequences in the saliva of patients with HIV infection. 143
Suscettibilità di batteri orali alla betadefensina umana 3, 143
Activity of human beta-defensin 3 alone or combined with other antimicrobial agents against oral bacteria 143
Anti-A and anti-B hemagglutinin depletion during Cohn purification process of 5% immunoglobulin 143
Surface acoustic wave-based lab-on-a-chip for the fast detection of Legionella pneumophila in water 142
Susceptibility of Streptococcus mutans and Actinobacillus actinomycetemcomitans to Bactericidal Activity of Human beta-Defensin 3 in Biological Fluids 141
The BCG1619c gene is not essential for invasion and intracellular persistence of Mycobacterium bovis BCG in human THP-1 and A549 cell lines 141
Antifouling Properties of Electrospun Polymeric Coatings Induced by Controlled Surface Morphology 141
Alta frequenza di isolamento di Streptococcus Mutans in bambini privi di lesioni cariose e con patologie ortodontiche. 139
Depression of the immune responsiveness in mice treated with thioacetamide after antigen exposure. 139
Effect of removable orthodontic appliances on oral colonisation by mutans streptococci in children 139
Biopharmaceutical Assessment of Mesh Aerosolised Plasminogen, a Step towards ARDS Treatment 138
Incidence of mutans streptococci in insulin-dependent diabetes mellitus patients 138
Combination of two kinds of medicated microparticles based on hyaluronic acid or chitosan for a wound healing spray patch 138
Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells 137
gamma-delta+ and CD4+alpha-beta+ human T cell subset responses upon stimulation with various Mycobacterium tuberculosis soluble extracts 136
Characterization of polysaccharide antigen of Streptococcus porcinus type II by monoclonal antibody 135
Three cases of human herpesvirus-6 latent infection: integration of viral genome in peripheral blood mononuclear cell DNA. 135
The secretion antigen SA5K has a role in the adaptation of Mycobacterium bovis bacillus Calmette-Guérin to intracellular stresses and hypoxia 134
QSAR Model on Adenosine Derivatives as Antifungal Agents against Candida albicans: a Data Mining Approach 133
Identification of novel proteins in culture filtrates of Mycobacterium bovis bacillus Calmette-Guerin in the isoelectric point range 6-11 133
Proliferation of distinct human T-cell subsets in response to live, killed or soluble extracts of Mycobacterium tuberculosis and Mycobacterium avium 133
Lactobacillus Probiotic Strains Differ in Their Ability to Adhere to Human Lung Epithelial Cells and to Prevent Adhesion of Clinical Isolates of Pseudomonas aeruginosa from Cystic Fibrosis Lung 132
In vitro expansion of T-cell-receptor Valpha2.3(+) CD4(+) T lymphocytes in HLA-DR17(3), DQ2(+) individuals upon stimulation with Mycobacterium tuberculosis 132
Hsp 60 promoter activity in recombinant Mycobacterium avium:LacZ during extra and intracellular growth 131
Serological identification of mutans Streptococci using MAbs in comparison with biochemical and DNA-DNA hibridisation techniques 131
QSAR model on adenosine derivatives as antifungal agents against Candida albicans: a data mining approach 131
Antimicrobial peptides and their interaction with biofilms of medically relevant bacteria 131
Emerging Multiscale Biofabrication Approaches for Bacteriotherapy 130
INVIVO STUDY OF THE INTERACTION OF HHV6 (HUMAN HERPESVIRUS-6) WITH HIV-1 130
STRUCTURAL AND STEREOSPECIFIC REQUIREMENTS FOR THE NUCLEOSIDE-TRIGGERED GERMINATION OF BACILLUS-CEREUS SPORES 129
Comparison of methods for the microbiological diagnosis of totally implantable venous access port-related infections 129
Totale 16.272
Categoria #
all - tutte 58.601
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.601


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021620 0 0 0 0 0 0 71 90 107 87 73 192
2021/20221.514 43 82 27 107 245 230 42 74 77 43 102 442
2022/20232.161 271 287 167 261 176 286 21 169 346 10 121 46
2023/20241.595 171 108 223 65 165 273 59 153 77 66 77 158
2024/20255.236 69 199 65 334 543 569 453 242 571 659 620 912
2025/20263.533 480 667 744 456 643 531 12 0 0 0 0 0
Totale 21.473